Report: Oriel Therapeutics Raises $2 Million for Inhaler

by WWW User — September 18, 2003

Oriel Therapeutics, which has developed a dry-power inhaler, recently closed on $2 million in investment from two other firms, The News & Observer reported Thursday.

PPD of Wilmington and Trudell Medical International of Canada made the investments, said Paul Atkins, chief executive officer of Oriel